Targeting survivin by a novel small molecule inhibitor, YM155 induces autophagic cell death in human breast cancer cells
碩士 === 國立成功大學 === 藥理學研究所 === 101 === Despite hormone therapy, targeted therapy and chemotherapy have been developed to target different types of breast cancer; the current breast cancer treatments still have several limitations and undesired side-effects. Thus, it is important to develop novel strat...
Main Authors: | Chih-YunLiu, 劉知耘 |
---|---|
Other Authors: | Chun Hei Antonio Cheung |
Format: | Others |
Language: | en_US |
Published: |
2013
|
Online Access: | http://ndltd.ncl.edu.tw/handle/24942197536310680653 |
Similar Items
-
Targeting of Survivin Pathways by YM155 Inhibits Cell Death and Invasion in Oral Squamous Cell Carcinoma Cells
by: Wei Zhang, et al.
Published: (2016-06-01) -
Function evaluation and mechanistic insight of the survivin suppressant, YM155, in breast cancer cells
by: Siao MukCheng, et al.
Published: (2019) -
The Mechanism of Radiosensitization by YM155, a Novel Small Molecule Inhibitor of Survivin Expression, is Associated with DNA Damage Repair
by: Songliu Hu, et al.
Published: (2015-09-01) -
Survivin selective inhibitor YM155 induce apoptosis in SK-NEP-1 Wilms tumor cells
by: Tao Yan-Fang, et al.
Published: (2012-12-01) -
Action of YM155 on clear cell renal cell carcinoma does not depend on survivin expression levels.
by: Mei Yi Sim, et al.
Published: (2017-01-01)